CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
Amniotic Fluid Injection +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04886960
NCT04886960Phase 2Completed
CompareCT.gov

A Phase I/II Randomized Double-Blinded Standard of Care (Corticosteroid) vs. Sterile Amniotic Fluid for Osteoarthritis

University of Utah·interventional·Posted May 14, 2021·Updated Mar 27, 2026

In Brief

A Phase 2 clinical trial evaluating Amniotic Fluid Injection and Standard of Care for Osteo Arthritis Knee. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This is a Phase I/II Randomized Double-Blinded Standard of Care (Corticosteroid) vs. Sterile Amniotic Fluid for Osteoarthritis

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteo Arthritis Knee
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20222023202420252026
First PostedMay 14, 2021
Enrollment StartJul 8, 2021
Primary CompletionJan 31, 2025
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 5.1 years ago

Interventions

Amniotic Fluid Injectionbiological

Comparison of Standard of Care (Corticosteroid) injection vs. Sterile Processed Amniotic Fluid Injection for Knee Osteoarthritis

Standard of Careother

Comparison of Standard of Care (Corticosteroid) injection vs. Sterile Processed Amniotic Fluid Injection for Knee Osteoarthritis